Summary & Overview
HCPCS G9292: Documentation of Medical Reason for Not Reporting Patient Category
HCPCS Level II code G9292 captures documentation of medical reasons for not reporting a patient category and includes a statement on tumor thickness and ulceration and, for pT1 lesions, mitotic rate. The code applies when pathology reports or clinical documentation explain why standard reporting elements are absent—examples include negative skin biopsies in patients with a history of melanoma or other documented medical reasons. Nationally, clear use of G9292 supports consistent clinical records and helps payers and providers align on documentation for atypical or incomplete pathology findings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical scope, typical settings where it is used, and what documentation the code is intended to represent. The publication also outlines common modifiers and related administrative details when provided, offers benchmark context where available, and situates the code within melanoma pathology and outpatient diagnostic workflows.
This summary serves clinicians, coders, and policy analysts seeking a national-level understanding of G9292’s purpose, typical use cases, and the documentation elements it conveys.
Billing Code Overview
HCPCS Level II code G9292 documents the medical reason(s) for not reporting patient category and provides a statement on tumor thickness and ulceration and, for pT1 lesions, the mitotic rate (for example, negative skin biopsies in a patient with a history of melanoma or other documented medical reasons). This code captures clinical documentation explaining why standard pathology or staging categories were not reported and supplies specific melanoma-related pathology details when available.
Service type: Pathology/Diagnostic Documentation and Medical Record Reporting
Typical site of service: Outpatient clinic or pathology laboratory associated with dermatology, oncology, or surgical services, where biopsy interpretation and documentation occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with a prior history of melanoma or a suspicious pigmented skin lesion presents for dermatologic evaluation after an external biopsy returned negative or nondiagnostic for invasive melanoma. The dermatologist documents the clinical decision that a tumor staging category (pathologic stage or primary tumor category) cannot be reported because pathologic features required for pT grouping are absent or unavailable (for example, only negative skin biopsies are present, or specimen lacks measurable thickness or ulceration). The medical record includes a clear medical reason for not reporting the patient category, a statement regarding tumor thickness and presence/absence of ulceration, and for pT1 tumors when applicable, documentation of mitotic rate. This coding event is typically generated by dermatology, dermatopathology, surgical oncology, or an outpatient procedure clinic when clinicians must formally record why standard pathologic staging elements are not reported. Typical site of service is an outpatient dermatology clinic, dermatopathology laboratory, or ambulatory surgery center where biopsy and pathology review occur. Common workflow: clinician performs or reviews biopsy results, documents the specific medical reason(s) for inability to report a pt category, records measurements or explanatory statements on thickness and ulceration (and mitoses when pT1 applies), signs the note, and submits the documentation as part of the medical record and billing process using G9292.
Coding Specifications
| Modifier | Description | When to Use |
|---|